Pathologic Features Associated With Molecular Subtypes of Well-Differentiated Thyroid Cancer-Reference-Cited by-同舟云学术

Pathologic Features Associated With Molecular Subtypes of Well-Differentiated Thyroid Cancer

Published:2021-03 Issue:3 Volume:27 Page:206-211
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Tang Alice L.,Kloos Richard T.,Aunins Benjamin,Holm Tammy M.,Roth Mara Y.,Yeh Michael W.,Randolph Gregory W.,Tabangin Meredith E.,Altaye Mekibib,Steward David L.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Next-generation sequencing in thyroid cancer;Cha;J Transl Med,2016

2. The role of BRAF in the pathogenesis of thyroid carcinoma;Li;Front Biosci (Landmark Ed),2015

3. RAS mutations in thyroid cancer;Howell;Oncologist,2013

4. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer;Xing;JAMA,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the ThyGeNEXT oncogene panel used in combination with the expanded miRNA panel ThyraMIRv2 in Indeterminate thyroid nodules: A large, blinded, real‐world, observational study;Cancer Cytopathology;2024-05-30

2. Long Non-Coding RNAs as Determinants of Thyroid Cancer Phenotypes: Investigating Differential Gene Expression Patterns and Novel Biomarker Discovery;Biology;2024-04-27

3. Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study;Endocrine Practice;2024-04

4. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high‐grade transformation from differentiated thyroid carcinoma;The Journal of Pathology: Clinical Research;2024-01-18

5. Combined Afirma Genomic Sequencing Classifier and TERT promoter mutation detection in molecular assessment of Bethesda III–VI thyroid nodules;Cancer Cytopathology;2023-08-06